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Liver Function Tests in Workers with
Occupational Exposure to Polychiorinated
Biphenyls (PCBs): Comparison with Yusho
and Yu-Cheng
by Alf Fischbein*
The results of liver function tests in a population manufacturing capacitors and transformers are pre-
sented. Two clinical field examinations were performed, one in 1976 when PCBs were still used in the
manufacturing of the electrical equipment and one at the end of 1979, 2.5 years after discontinuation of
PCBs use. A low prevalence ofabnormal liver function tests was found and mean values for all tests were
within normal laboratory ranges. Atthe initial examination, weak, butstatistically significantcorrelations
were found between log LDH and plasma levels of log HPCB (higher chlorinated congeners of polychlo-
rinated biphenyls) and log TPCB (total polychlorinated biphenyls) among the female workers, while log
,y-GTP correlated significantly only with log HPCB among the male workers. A significant increase to
abnormal levels of -y-GTP was noted at the follow-up examination in both male and female workers, and
preliminary results indicate significant correlations between y-GTP and serum levels ofPCBs among the
male workers.
These findings are in accordance with previously reported data on populations occupationally exposed
toPCBs, butdifferfrom hepatic biochemistry findings in accidental poisoningsdueto ingestion ofcooking
oil contaminated with PCBs and related compounds, i.e., polychlorinated dibenzofurans (PCDFs) and
polychlorinated quaterphenyls (PCQs). Hence, the importance of considering the related compounds as
etiologic factors in PCB poisoning is emphasized.
Introduction
Polychlorinated biphenyls (PCBs), a group of chem-
icals consisting of complex mixtures of chlorinated bi-
phenyls (1), have been used industrially since the late
1920s. Their chemical stability and nonconductor qual-
ities have rendered them very useful as dielectric fluids
in capacitors and transformers. They have also been
used in hydraulic systems and as additives in paints,
surface coatings, and in carbonless copy papers.
The widespread contamination ofthe human environ-
ment by PCBs was reported in 1966 (2), and concern
over possible harmful effects on human health caused
manufacturing of PCBs in the United States to be dis-
continued in 1977 (3,4).
There is extensive literature reporting toxic effects
of PCBs on various organ systems in experimental an-
imals(5). Awide spectrumofhepaticabnormalities have
been observed, including hepatic enlargement and
weight increase related to hepatic cell hypertrophy and
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increase in the smooth endoplasmic reticulum (6); no-
dular hyperplasia and hepatocellular carcinoma have also
been observed in PCB-treated certain strains of rats
and mice (7,8). Association between hepatic effects and
degree of chlorination, has also been suggested (9).
In contrast, effects ofPCBs on humans are more un-
certain, but liver function abnormalities have been re-
ported with either accidental or occupational exposures
to PCBs. Early studiesinvolvingoccupational exposure
reported acute hepatic disease, i.e., acute yellow atro-
phy (10,11). Abnormal liver function tests were also
found inpatientswith severe "Yusho", representingthe
first major outbreak of PCBs poisoning (12). Similar
findings were reported in patients from a second epi-
demicofPCB intoxication ("Yu-Cheng") in Taiwan (13).
(Names given to the diseases observed in connection
with two major epidemics ofpoisoning due to ingestion
ofoil contaminated with PCBs and related compounds.
Yusho isJapanese for "oil disease" and Yu-Chengis the
Chinese rendering of the same.) Nevertheless, more
recent investigations of occupationally exposed popu-
lations report absence ofclinically manifesthepatic dys-
functioningeneral (14-17). AttentionhasbeendirectedA. FISCHBEIN
to the role of polychlorinated dibenzofurans (PCDFs)
and polychlorinated quaterphenyls (PCQs) as etiologic
factors causing "PCB-associated" disease (18). In this
context, one should consider that simultaneous expo-
sure to other chlorinated compounds, i.e., chlorinated
naphthalenes, occurred in workers exposed to PCBs,
who developed acute yellow atrophy ofthe liver (10, 11,
19). This condition has been reported in workers with
exposure to chlorinated naphthalenes alone (20).
In this communication, we present the results ofliver
function tests in a group of workers manufacturing ca-
pacitors and transformers and discuss these findings in
relation to observations made in Yusho and Yu-Cheng.
Materials and Methods
In order to investigate health effects associated with
long-term occupational exposure to PCBs, a cross-sec-
tional study was conducted in March 1976 on 326 work-
ers employed at two facilities where capacitors were
manufactured. PCB-containing dielectric fluid had been
used at the plants since the late 1940s, and there was
potential for exposure alongmost ofthe production line.
Different PCB mixtures had been used over the years.
Duringthe 1940sand 1950s, thedielectric fluidconsisted
primarily of PCB compounds with higher chlorinated
congeners (HPCB), such as Aroclor 1254 and 1242. In
contrast, since 1972, i.e., 4 years prior to the initial
phase of the study, lower chlorinated PCBs (LPCB)
such as Aroclor 1016 and 1221, had been the main com-
pounds used in the manufacturing process. In addition
to PCBs, the dielectric fluid contained chlorinated ben-
zenes and an epoxide compound used as a stabilizer.
The intensity of exposure ranged from mean air levels
of0.007 mg/m air in areas with the lowest exposures to
0.41 mg/m in departments where more direct contact
with the fluid was required, as in the testing of equip-
ment and in the quality control area. Air levels of 0.9
mg/m and 11.0 mg/m were measured in areas where
equipment was immersed in the dielectric fluid or
washed.
Exposure occurred mainly from inhalation of fumes
released from heated fluid, but both skin contact and
ingestion may have been significant routes of entry as
well.
The population was selected from a total workforce
of approximately 800 individuals. The most important
criterion for inclusion in the study group was employ-
ment for ten or more years, but some individuals with
less than 10 years of employment who came for exam-
ination were also included. All were volunteers. Meth-
odological aspects of this investigation have been
summarized elsewhere (21).
PCB determinations were done by gas chromatog-
raphy (22) on plasma samples (initial study) and serum
samples (follow-up study) obtained from venous blood
samples. PCB levels were initially available for analysis
on 289 individuals. Liver function tests included y-glu-
tamyl transpeptidase (-y-GTP), serum glutamic-oxala-
cetic transaminase (SGOT), serum glutamic-pyruvic
transaminase (SGPT), alkaline phosphatase (alk. phos.),
lactic dehydrogenase (LDH) and bilirubin. These were
all measured by a sequential multiple auto analyzer
system.
Excluded from the analysis were subjects with a his-
tory ofthe following: using oral contraceptives or other
sex hormones, steriods, excessive alcohol consumption,
jaundice, infectious hepatitis, and enlarged liver. These
individuals were excluded because of potential inter-
ference and confounding effects on liver function. Thus,
261 individuals were included in the analysis. Twenty-
eight retired workers were initially excluded in the cor-
relational analyses between "current exposure" and bi-
ological parameters. However, the effect of their
inclusion was also investigated (see below in Results).
The use of PCBs was discontinued in the manufac-
turingfacilities inJuly 1977, and industrial hygiene sur-
veys conducted during the period between the studies
provided evidence that there had been a marked de-
crease in air levels of PCBs (23). A mixture of dioctyl
phthalate and chlorinated benzenes replaced the PCBs
containing compound as dielectric fluid. Follow-up ex-
amination of 194 subjects was performed in December
1979, threeyears and nine months afterthe initial study.
Statistical analysis was undertaken, using the Statis-
ticalAnalysis System (SAS) and the Statistical Package
for the Social Sciences (SPSS). Because of the distri-
bution of the data, logarithmic transformations were
used in the statistical correlations.
Differences in mean values were calculated by Stu-
dent's t-testforpaired dataand changesinliverfunction
tests from normal to abnormal range were calculated
by McNemar's test ofsymmetry. Associations between




The duration ofemployment, shown in Table 1, dem-
onstrates that 68% of the subjects had been employed
for 10 years or longer; 37% had 20 or more years' du-
rationofemployment; 64%were40yearsofageorolder.
The age and sex distributions ofthe examined workers
are shown in Table 2.
Plasma PCB concentrations ofthe examined workers
Table 1. Duration of employment of 260 workers manufacturing
capacitors.
Male workers Femaleworkersa Total workers
Duration, yr No. % No. % No. %
0-9 59 41 24 21 83 32
10-19 34 23 46 40 80 31
>20 53 36 44 39 97 37
Total 146 100 114 100 260 100
aDuration of employment not available for one female worker.
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(Table 3) indicated a high prevalence of elevated PCB
levels suggesting significant absorption in the majority
of subjects. For 35% of the workers the LPCB level
was 100 ppb or higher, while 44% had HPCB concen-
tration of 25 ppb or higher.
Mean values of the liver function tests and preva-
lences of abnormal levels are shown in Tables 4 and 5.
Although significant differences in liver function tests
were foundbetweenmale andfemaleworkers, the mean
values werewellwithinnormallimitsforalltests. More-
over, the prevalence of abnormal liver function tests
was comparable with that reported in a study of a gen-
eral population (24).
No significant correlation was found bvetween any of
the liver function tests and duration of employment.
Table 2. Age distribution of 261 workers manufacturing
capacitors.
Male workers Female workers Total workers
Age No. % No. % No. %
20-39 68 47 24 21 92 36
40-49 44 30 32 28 76 29
50-59 28 19 54 47 82 31
>60 6 4 5 4 11 4
Total 146 100 115 100 261 100
Table 3. Plasma concentrations of lower (LPCB) and higher
(HPCB) homologs of PCBs in 230 workers manufacturing
capacitors.a
Typeof Conen, Male workers Female workers Total workers
PCB ppb No. % No. % No. %
LPCB 0-99 85 62 66 70 151 65
100-199 28 21 17 18 45 20
>200 23 17 11 12 34 15
Total 136 100 94 100 230 100
HPCB 0-24 68 50 60 64 128 56
25-74 50 37 24 26 74 32
> 75 18 13 10 10 23 12
Total 136 100 94 100 230 100
aPlasma PCB concentrations not available on 31 workers, 10 males
and 21 females
Only one significant correlation was found between age
and a liver function test, namely, with alkaline phos-
phatase, and this was observed solely among the male
workers.
Pearson correlation coefficients between liver func-
tion tests and plasma PCB levels are shown in Table 6.
Significant correlations were limited to those between
log LDH vs. log HPC and log TPC, and between log y-
GTP and log HPCB. While "statistically significant,"
the correlation coefficients were low. When liver func-
tion tests were computed against PCB levels applying
Fisher's exact test, significant associations were found
between SGOT and both HPCB and LPCB. This as-
sociation was only significant for the female workers;
the small number of abnormal observations should not
be overlooked (Tables 7 and 8).
Since this analysis addressed only actively employed
workers, it was of interest to investigate whether the
inclusion of28 retirees (11 males and 17 females) would
significantly influence the correlational study. The in-
clusion of these individuals eliminated the previsouly
observed significant correlations between log -y-GTP and
log HPCB in the male workers and also rendered the
correlation between log LDH and log TPCB observed
among the female workers nonsignificant. The associ-
ation between SGOT and both HPCB and LPCB ob-
served among the female workers remained the same.
Follow-up Examination
Atthe present time, the analysis ofthe data from the
follow-up examination is in progress, and the observa-
Table 4. Liver function test results (mean ± SD) in 144 male
workers and 112 female workers manufacturing capacitors.a
Female workers Male workers
Test Mean + SD Mean ± SD
SGOT, IU/L 24.8 ± 11.4 27.1 ± 10.8
SGPT, IU/L 25.5 ± 13.1 31.2 ± 13.5
Alkaline phosphatase, IU/L 25.6 ± 8.7 26.2 ± 6.9
LDH, IU/L 175.9 ± 30.8 167.1 ± 25.7
X-GTP, F.L 10.8 ± 7.5 15.7 ± 9.0
aRetirees excluded.
Table 5. Liver function test results in 261 capacitor manufacturing workers.
Male workers Female workers Total workers
Normal Abnormal Normal Abnormal Normal Abnormal
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
SGOT, IU/L < 50 ¢ 50 < 50 50 < 50 : 50
142(97) 4(3) 113(98) 2(2) 255(98) 6(2)
SGPT, IU/L < 50 a 50 < 50 ¢ 50 < 50 50
134(92) 12(8) 108(94) 7(6) 242(93) 19(7)
LDH, IU/L < 250 ¢ 250 < 250 ¢ 250 250 2 250
145(99) 1(1) 111(97) 4(3) 256(98) 5(2)
Alkaline phosphatase, IU/L < 50 : 50 < 50 > 50 < 50 2 50
145(99) 1(1) 113(98) 2(2) 258(99) 3(1)
y-GTP, ILL < 40 a 40 < 40 > 40 < 40
- 40
143(98) 3(2) 113(98) 2(2) 256(98) 5(2)
Bilirubin, mg/100 mL < 1.2 > 1.2 < 1.2 3 1.2 < 1.2 3 1.2
146(100) 0(0) 115(100) O(O) 261(100) 0(0)
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Table 6. Pearson correlation coefficients between liver function
tests and plasma PCBs levels in 93 female workers and
134 male workers manufacturing capacitors.ab
log (LPCB) log (HPCB) log (TPCB)
Females
log (SGOT) 0.126 (0.228) 0.049 (0.638) 0.105 (0.316)
log (SGPT) 0.135 (0.197) 0.089 (0.396) 0.120 (0.251)
log (alk.
phos.) - 0.032 (0.758) 0.144 (0.169) 0.015 (0.885)
log (LDH) 0.182 (0.080) 0.240 (0.021) 0.213 (0.040)
log (y-GTP) - 0.168 (0.107) - 0.112 (0.286) - 0.173 (0.097)
log (bilirubin) 0.062 (0.551) 0.017 (0.877) 0.040 (0.702)
Males
log (SGOT) 0.117 (0.179) 0.118 (0.175) 0.127 (0.143)
log (SGPT) 0.066 (-0.449) - 0.007 (0.936) 0.058 (0.505)
log (alk.
phos.) - 0.092 (0.288) - 0.003 (0.972) - 0.065 (0.453)
log (LDH) 0.004 (0.961) 0.079 (0.366) 0.019 (0.828)
log (y-GTP) - 0.010 (0.912) 0.175 (0.043) 0.059 (0.497)
log (bilirubin) 0.065 (0.452) 0.089 (0.315) 0.021 (0.803)
ap values are in parentheses. Significant correlations are italic.
bRetirees excluded.
tions presented on a subset of 105 individuals of the
studypopulation arepreliminary andlimited tothe liver
function tests. (Changes in serum concentrations ofPCBs
overthe 45-month period that elapsed between the two
clinical field examinations will be reported elsewhere.)
Although there was a significant decrease in mean val-
ues of most liver function tests, namely SGOT, SGPT,
bilirubin and LDH, a significant increase in mean con-
centrations were noted for -y-GTP and alkaline phos-
phatase. However, only for -y-GTP was significant
alteration from normal to abnormal range noted. For
this variable, the increase in abnormallevels washighly
significant (X2 (McN) = 25.04, p < 0.001). Moreover,
significant correlations were found among the male
workers between log y-GTP and log LPCB, log HPCB
and log TPCB. The Pearson correlation coefficients were
0.34 (p = 0.02), 0.39 (p = 0.007) and 0.38 (p = 0.01),
respectively. [At the initial examination, low but sig-
nificant correlation was only noted between log -y-GTP
and log HPCB (r = 0.18, p = 0.04)]. Significant cor-
relation was also noted between log SGPT and log HPCB
among the male workers (r = 0.31, p = 0.04), again a
change from the initial examination. There were no sig-
nificant correlations between any of the liver function
tests and serum levels ofPCBs amongthe female work-
ers hitherto re-examined. Inclusion of retirees in the
above calculations eliminated all the significant corre-
lations between liver function tests and PCB levels.
Discussion
Although there is ample evidence of the hepatic ef-
fects ofPCBs in experimental animals, liver abnormal-
ities in humans have been less well characterized.
Clinical syndromes thought to be characteristic ofPCB
poisoning were reported in connection with two major
accidents involving ingestion of PCB-contaminated
cooking oil. The first was the so-called Yusho (Japanese
Table 7. Distribution of SGOT levels by HPCB categories in 93
female workers manufacturing capacitors.a
SGOT normal SGOT abnormal
HPCB Number (%) Number (%) Total
£ 75 83 (100) 0 (0) 83
> 8 (80) 2 (20) 10
Total 91 2 93
aFisher's exact test (one-tail): p = 0.01.
Table 8. Distribution of SGOT levels by LPCB categories in 93
female workers manufacturing capacitors.a
SGOT normal SGOT abnormal
LPCB Number (%) Number (%) Ttal
<200 83 (100) 0 (0) 83
V200 8 (80) 2 (20) 10
obtal 91 2 93
aFishers exact test (one-tail): p = 0.01.
for "oil disease") episode. Initial studies on Yusho pa-
tients did reveal abnormalties in routine liver function
tests in severe cases. Also, hepatomegaly was found in
some patients. Although no light microscopic changes
wererevealedinhepaticbiopsyspecimensfrom aYusho
patient, electron microscopic analysis did show altera-
tions in the endoplasmic reticulum and in the mitochon-
dria (12). It has been suggested that these changes may
be morphological manifestations related to enzyme in-
duction caused by PCBs, which has been demonstrated
in both experimental and clinical studies (25,26). Ana-
logously, there was a high prevalence ofabnormal liver
function tests, i.e., SGOT, SGPT and alkaline phospha-
tase, among36patientswith severe signsofintoxication
in connection with a second major accidental intoxica-
tion episode in Taiwan known as Yu-Cheng (27).
Abnormalities in liver function have been reported in
populations employed in PCBs-related occupations, but
in most studies, liver function abnormalities have been
mild, and overt clinically significant liver disease as re-
flected by anamnesis and physical examination, has
rarely been reported. (14-17,28)One exception is the
study by Maroni et al.(29), reporting a high prevalence
ofbiochemical liver abnormalities and hepatomegaly on
physical examination. Nevertheless, even in studies re-
porting a low prevalence of liver abnormalities, signif-
icant correlations have been found between serum PCB
levels(bothHPCBandLPCB), SGOTand y-GTP(15,16).
In the present investigation, liver function tests in
workers employed in capacitor and transformer man-
ufacturing were studied. Few abnormalities were ob-
served, and mean values for liver function tests were
withinnormallaboratorylimits. Inclusion ofretired em-
ployees did not add to the prevalence of liver function
abnormalities, butrathereliminated twosignificant cor-
relations, namely between log LDH and log TPCB in
the female workers, and the correlation between log y-
GTP and log HPCB among the male workers. Signifi-
cant association between SGOT levels and serum levels
ofboth HPCB and LPCB were found for the total pop-
ulation (males and females), but the association re-
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mained significant only for the female workers when
analyzed separately. However, the small number ofab-
normal liver function observations should be recognized
in this context. Preliminary data from afollow-up study
indicated a significant increase in the prevalence ofab-
normal values ofy-GTP, and significant correlations were
found between y-GTP and serum levels ofPCBs among
the male workers. Inclusion of retirees in the calcula-
tions eliminated the statistical significance of these
correlations.
It is evident from our data that there is a difference
in severity of clinical manifestations between patients
with either Yusho or Yu-Cheng and those with effects
of occupational exposure to PCBs. This "discrepancy"
is interesting, since occupationally exposed individuals
studied have had higher serum or plasma PCB levels
in general than the typical patients. In discussing this
discrepancy, it would seem pertinent to consider the
possibility that contaminants may play an important
causativeroleinthepathogenesis ofPCBpoisoning(30).
During the past decade, evidence has accumulated that
the rice oil ingested by patients with Yusho also con-
tained polychlorinated dibenzofurans (PCDFs) and pol-
ychlorinated quaterphenyls (PCQs). Both have been
found in the blood and other organs of the Japanese
patients (31,32). Similar observations have been made
in Taiwanese patients (33). It is also of interest that
experiments on primates using a mixture of PCDFs
similar to those in the Japanese oil showed both der-
matological and systemic changes suggestive ofYusho,
but that the administration ofPCBs or PCQs alone failed
to induce such changes in either primates or rats (31).
A recent study on three PCB-exposed occupational
groups in Japan followed over a 5-year period can be
considered as a clinical correlate to these observations
in experimental animals. Despite high plasma PCB lev-
els, hepatic function was reported normal. Plasma con-
centration of PCQs in two of the occupational groups
examined were the same as in the general nonexposed
population (34).
Although levels of PCDFs and other contaminants
are unavailable on our study population at the present
time, it seems apparent from our observations and the
results oftheJapanese study ofPCB-exposed workers,
(34) that the mere presence of a high plasma or serum
level of PCBs (in the absence of significant levels of
PCDFs and/or PCQs) is not necessarily associated with
overt clinical liver disease. It is still possible, however,
that "subclinical" alterations are present in such work-
ers as suggested by the enzyme-inducing capacity of
PCBs (26). Our findings are also in accordance with
currently prevailing concepts of several authors that
PCDFs, PCQs and perhaps other contaminants such as
chlorinated diphenyl ethers, should be considered as
important etiological factors in clinical "PCB poisoning"
(18,30-34).
The increase in prevalence of abnormal levels of -y-
GTP observed between our original and follow-up ex-
aminations is intriguing. A correlation was found be-
tween -y-GTP and serum levels ofPCBs amongthe male
workers not previously observed in our initial study.
Further analysis is in progress in order to clarifywhether
these findings might be related to changes in the work
environment asaresultofdiscontinuingtheuseofPCBs
with subsequent metabolic implications in terms of al-
tered pharmacokinetics of PCBs, and the introduction
ofreplacement materials.
Mortality studies ofPCB-exposed workers have been
suspect but have not yet provided conclusive evidence
ofan increased risk ofliver cancer. However, two cases
ofhepatic cell carcinoma have been reported in autopsy
examinations of12 "Yusho" patients (35,36). Additional
observations are necessary to clarify an etiological re-
lationshipbetweenPCB-related occupations andthe de-
velopment of hepatic disease.
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